1. Un neuroleptique majeur non phenothiazinique et non reserpinique, 1' halidol, dans le traitment des psychoses;Delay, J.; Pichot, P.; Lemperier, M.T.; Ellisalde, B.; Peigne, F.;Ann Med Psychol (Paris)
2. A prospective survey ofneuroleptic malignant syndrome in a short term psychiatric hospital;Gelenberg, A.J.; Bellinghausen, B.; Wojcik, J.D.; Falk, W.E.; Sachs, G.S.;Am J Psychiatry,1988
3. Frequency and presentation of neuroleptic malignant syndrome: a prospective study;Keck, P.E.; Pope, H.G.; Mcelroy, S.L.;Am J Psychiatry,1987
4. Neuroleptic malignant syndrome;Caroff, S.N.; Mann, S.C.;Med Clin North Am,1993
5. Declining frequency of neuroleptic malignant syndrome in a hospital population;Keck, P.E.; Pope, H.G.; Mcelroy, S.L.;Am J7 Psychiatry,1991